S-adenosylmethionine administration inhibits levodopa-induced vascular endothelial growth factor-A expression | Zendy

Yuanliang Yan | Zendy; Qijia Yan | Zendy; Long Qian | Zendy; Yueping Jiang | Zendy; Xi Chen | Zendy; Shuangshuang Zeng | Zendy; Zhijie Xu | Zendy; Zhicheng Gong | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

S-adenosylmethionine administration inhibits levodopa-induced vascular endothelial growth factor-A expression

Author(s) -

Yuanliang Yan,

Qijia Yan,

Long Qian,

Yueping Jiang,

Xi Chen,

Shuangshuang Zeng,

Zhijie Xu,

Zhicheng Gong

Publication year - 2020

Publication title -

aging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.473

H-Index - 90

ISSN - 1945-4589

DOI - 10.18632/aging.103863

Subject(s) - vascular endothelial growth factor , vascular endothelial growth factor b , pharmacology , levodopa , administration (probate law) , vascular endothelial growth factor c , chemistry , microbiology and biotechnology , vascular endothelial growth factor a , medicine , vegf receptors , biology , cancer research , political science , parkinson's disease , disease , law

Studies have demonstrated that S-adenosylmethionine could effectively affect the clinical wearing-off phenomena of levodopa, an antiparkinsonian agent; however, the detailed mechanisms for this effect need to be further clarified.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research